1
|
Paul P, Janjua E, AlSubaie M, Ramadorai V, Mushannen B, Vattoth AL, Khan W, Bshesh K, Nauman A, Mohammed I, Bouhali I, Khalid M, Zakaria D. Breathless encounters: Analyzing anaphylaxis at the crossroads of COVID-19 vaccination. Qatar Med J 2024; 2024:9. [PMID: 38680410 PMCID: PMC11046092 DOI: 10.5339/qmj.2024.qitc.9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2024] [Accepted: 01/31/2024] [Indexed: 05/01/2024] Open
Affiliation(s)
- Pradipta Paul
- Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, PO Box 24144, Doha, Qatar
| | - Emmad Janjua
- Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, PO Box 24144, Doha, Qatar
| | - Mai AlSubaie
- Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, PO Box 24144, Doha, Qatar
| | - Vinutha Ramadorai
- Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, PO Box 24144, Doha, Qatar
| | - Beshr Mushannen
- Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, PO Box 24144, Doha, Qatar
| | - Ahamed Lazim Vattoth
- Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, PO Box 24144, Doha, Qatar
| | - Wafa Khan
- Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, PO Box 24144, Doha, Qatar
| | - Khalifa Bshesh
- Department of Medicine, The Johns Hopkins Hospital, Baltimore, Maryland, USA
| | - Areej Nauman
- Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, PO Box 24144, Doha, Qatar
| | - Ibrahim Mohammed
- Department of Internal Medicine, Albany Medical Center Hospital, Albany, New York, USA
| | - Imane Bouhali
- Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, PO Box 24144, Doha, Qatar
| | - Mohammed Khalid
- Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, PO Box 24144, Doha, Qatar
| | - Dalia Zakaria
- Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, PO Box 24144, Doha, Qatar
| |
Collapse
|
2
|
Paul P, Janjua E, AlSubaie M, Ramadorai V, Mushannen B, Vattoth AL, Khan W, Bshesh K, Nauman A, Mohammed I, Bouhali I, Khalid M, Zakaria D. Anaphylaxis and Related Events Post-COVID-19 Vaccination: A Systematic Review. J Clin Pharmacol 2022; 62:1335-1349. [PMID: 35794852 PMCID: PMC9349886 DOI: 10.1002/jcph.2120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2022] [Accepted: 06/29/2022] [Indexed: 11/10/2022]
Abstract
The Coronavirus Disease 2019 (COVID-19), induced by the SARS CoV-2 virus, is responsible for a global pandemic following widespread transmission and death. Several vaccines have been developed to counter this public health crisis using both novel and conventional methods. Following approval based on promising efficacy and safety data, the AstraZeneca, Janssen, Moderna, Pfizer/BioNTech, and SinoVac vaccines have been administered globally among different populations with various reported side effects. Reports of life-threatening anaphylaxis following administration were of particular concern for both healthcare providers and the public. A systematic literature search using PubMed, Embase, Scopus, Web of Science, Science Direct, MedRxiv, and Lens.org databases identified relevant studies reporting anaphylaxis following vaccine administration. This systematic review includes 41 studies reporting anaphylaxis out of 19908 studies that were retrieved for screening. A total of 7942 cases, including 43 deaths, were reported across 14 countries. Most cases occurred following the administration of the first dose. Importantly, the benefits of vaccination far outweigh the risks of anaphylaxis. Subsequently, as populations continue to get vaccinated, it is important for healthcare providers to be able to recognize individuals at risk of developing anaphylaxis. Furthermore, they must be familiar with both the clinical hallmarks and treatment of anaphylactic reactions to minimize long term sequalae and prevent death in vaccinated individuals. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Pradipta Paul
- Weill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar
| | - Emmad Janjua
- Weill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar
| | - Mai AlSubaie
- Weill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar
| | - Vinutha Ramadorai
- Weill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar
| | - Beshr Mushannen
- Weill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar
| | | | - Wafa Khan
- Weill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar
| | - Khalifa Bshesh
- Weill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar
| | - Areej Nauman
- Weill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar
| | - Ibrahim Mohammed
- Weill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar.,Internal Medicine, Albany Medical Center Hospital, Albany, New York, USA
| | - Imane Bouhali
- Weill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar
| | - Mohammed Khalid
- Weill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar
| | - Dalia Zakaria
- Weill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar
| |
Collapse
|